122 related articles for article (PubMed ID: 2397113)
1. Fibronectin: a discrimination marker between small invasive carcinomas and benign proliferative lesions of the breast.
Christensen L
APMIS; 1990 Jul; 98(7):615-23. PubMed ID: 2397113
[TBL] [Abstract][Full Text] [Related]
2. Stromal fibronectin staining pattern and metastasizing ability of human breast carcinoma.
Christensen L; Nielsen M; Andersen J; Clemmensen I
Cancer Res; 1988 Nov; 48(21):6227-33. PubMed ID: 2458833
[TBL] [Abstract][Full Text] [Related]
3. Differences in tetranectin immunoreactivity between benign and malignant breast tissue.
Christensen L; Clemmensen I
Histochemistry; 1991; 95(5):427-33. PubMed ID: 1651300
[TBL] [Abstract][Full Text] [Related]
4. Expression of fibronectin isoforms in human breast tissue: production of extra domain A+/extra domain B+ by cancer cells and extra domain A+ by stromal cells.
Matsumoto E; Yoshida T; Kawarada Y; Sakakura T
Jpn J Cancer Res; 1999 Mar; 90(3):320-5. PubMed ID: 10359047
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical fibronectin staining pattern and prognosis in invasive breast carcinoma.
Takei H; Iino Y; Horiguchi J; Yokoe T
Oncology; 1995; 52(2):106-11. PubMed ID: 7854768
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions.
Bier B; Douglas-Jones A; Tötsch M; Dockhorn-Dworniczak B; Böcker W; Jasani B; Schmid KW
Breast Cancer Res Treat; 1994; 30(3):213-21. PubMed ID: 7981441
[TBL] [Abstract][Full Text] [Related]
7. Expression of a new mucin-type glycoprotein in select epithelial dysplasias and neoplasms detected immunocytochemically with Mab A-80.
Shin SS; Gould VE; Gould JE; Warren WH; Gould KA; Yaremko ML; Manderino GL; Rittenhouse HG; Tomita JT; Jansson DS
APMIS; 1989 Dec; 97(12):1053-67. PubMed ID: 2611021
[TBL] [Abstract][Full Text] [Related]
8. In vivo demonstration of cytoplasmic fibronectin in human breast carcinomas.
Christensen L; Nielsen M; Hølund B; Clemmensen I
Virchows Arch A Pathol Anat Histopathol; 1985; 407(3):337-46. PubMed ID: 3929464
[TBL] [Abstract][Full Text] [Related]
9. Are epithelial cells in fat or connective tissue a reliable indicator of tumor invasion in fine-needle aspiration of the breast?
Maygarden SJ; Brock MS; Novotny DB
Diagn Cytopathol; 1997 Feb; 16(2):137-42. PubMed ID: 9067105
[TBL] [Abstract][Full Text] [Related]
10. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
11. Laminin production and fibronectin immunoreactivity in breast carcinomas.
Gorczyca W; Holm R; Nesland JM
Anticancer Res; 1993; 13(4):851-8. PubMed ID: 8394677
[TBL] [Abstract][Full Text] [Related]
12. [Small focal lesions of the breast: a clinico-morphological analysis].
Serov VV; Kuzin MI; Zolotarevskiĭ VB; Zal'tsman IN; Kulakova AM
Arkh Patol; 1984; 46(9):25-32. PubMed ID: 6095796
[TBL] [Abstract][Full Text] [Related]
13. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
15. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
[TBL] [Abstract][Full Text] [Related]
16. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
Kővári B; Báthori Á; Cserni G
Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Kossakowska AE; Huchcroft SA; Urbanski SJ; Edwards DR
Br J Cancer; 1996 Jun; 73(11):1401-8. PubMed ID: 8645587
[TBL] [Abstract][Full Text] [Related]
19. Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells.
Nesland JM; Lunde S; Holm R; Johannessen JV
Histol Histopathol; 1987 Jan; 2(1):73-7. PubMed ID: 2980706
[TBL] [Abstract][Full Text] [Related]
20. Paucity of fibronectin in invasive lobular carcinoma of breast.
D'Ardenne AJ; Barnard NJ
J Pathol; 1989 Mar; 157(3):219-24. PubMed ID: 2538611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]